SCHEMBL5182011

SCHEMBL5182011

c1ccc2oc(-c3ccc(CCc4ccc(-c5nc6ccccc6o5)cc4)cc3)nc2c1

nearest known ligand 0.76

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.76
TP53 P04637 2/20 0.76
SMN1; SMN2 Q16637 2/20 0.76
KDM4E B2RXH2 1/20 0.76
ALDH1A1 P00352 1/20 0.76
HPGD P15428 1/20 0.76
HSD17B10 Q99714 1/20 0.76
RAB9A P51151 2/20 0.67
MEN1 O00255 1/20 0.67
KMT2A Q03164 1/20 0.67
ATM Q13315 1/20 0.67
BCHE P06276 1/20 0.59
MMP2 P08253 1/20 0.58
MMP9 P14780 1/20 0.58
MMP8 P22894 1/20 0.58
MMP13 P45452 1/20 0.58
MAPT P10636 1/20 0.55
HTT P42858 1/20 0.55
GFER P55789 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6329882 0.92 NPC1 (0.68) NPC1TP53SMN1; SMN2KDM4EALDH1A1
SCHEMBL11368928 0.90 NPC1 (0.68) NPC1TP53SMN1; SMN2KDM4EALDH1A1
Hydrochloric Acid SCHEMBL8983501 0.90 NPC1 (0.77) NPC1TP53SMN1; SMN2KDM4EALDH1A1
SCHEMBL28868163 0.90 NPC1 (0.68) NPC1TP53SMN1; SMN2KDM4EALDH1A1
SCHEMBL31170 0.89 NPC1 (0.81) NPC1TP53SMN1; SMN2KDM4EALDH1A1
SCHEMBL8983405 0.88 NPC1 (0.64) NPC1TP53SMN1; SMN2KDM4EALDH1A1
SCHEMBL28266940 0.88 NPC1 (0.64) NPC1TP53SMN1; SMN2KDM4EALDH1A1
SCHEMBL31476 0.87 NPC1 (0.79) NPC1TP53SMN1; SMN2KDM4EALDH1A1
Methane SCHEMBL29265168 0.87 NPC1 (0.79) NPC1TP53SMN1; SMN2KDM4EALDH1A1
SCHEMBL11701224 0.86 NPC1 (0.71) NPC1TP53SMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3823811-B1 PRODUCTION OF MOLDED BODIES FROM AN INORGANIC-ORGANIC HYBRID POLYMER WITH HIGH RESOLUTION USING 3D PRINTING, MOLDED BODIES WITH A HIGH FLEXURAL STRENGTH AND ELASTIC MODULUS, AND THE USE THEREOF FOR DENTAL PURPOSES FRAUNHOFER GES FORSCHUNG (DE) 2023-11-08 EP disclosed
WO-2023012058-A1 DENTAL IMPLANT MESOSTRUCTURES HAVING A SHAPE MEMORY EFFECT Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2023-02-09 WO disclosed
EP-3318920-B1 NEAR INFRARED LIGHT-CUTTING OPTICAL ARTICLES WITH LOW RESIDUAL COLOR ESSILOR INT (FR) 2022-07-06 EP disclosed
US-11124599-B2 Near infrared light-cutting optical articles with low residual color ESSILOR INTERNATIONAL (FR) 2021-09-21 US disclosed
CN-112522942-A Soil repellent fiber and method for producing the same 英威达纺织(英国)有限公司 2021-03-19 CN disclosed
EP-3203271-B1 BLUE LIGHT CUTTING OPTICAL MATERIAL COMPRISING A BENZOTRIAZOLE UV ABSORBER ESSILOR INT (FR) 2021-01-27 EP disclosed
US-20200262967-A1 NEAR INFRARED LIGHT-CUTTING OPTICAL ARTICLES WITH LOW RESIDUAL COLOR ESSILOR INTERNATIONAL (FR) 2020-08-20 US disclosed
EP-2887129-B1 Transparent optical article having a colorless appearance ESSILOR INT (FR) 2020-04-22 EP disclosed
EP-3087419-B1 TRANSPARENT OPTICAL ARTICLE HAVING A REDUCED YELLOWNESS APPEARANCE ESSILOR INT (FR) 2020-04-15 EP disclosed
US-10308618-B2 Blue light cutting optical material comprising a benzotriazole UV absorber ESSILOR INTERNATIONAL (FR) 2019-06-04 US disclosed
WO-2017137372-A1 BLUE LIGHT CUTTING OPTICAL MATERIAL COMPRISING A BENZOTRIAZOLE UV ABSORBER Essilor International (Compagnie Générale d'Optique) (FR) 2017-08-17 WO disclosed
EP-3203271-A1 BLUE LIGHT CUTTING OPTICAL MATERIAL COMPRISING A BENZOTRIAZOLE UV ABSORBER ESSILOR INTERNATIONAL (Compagnie Générale d'Optique) (FR) 2017-08-09 EP disclosed
US-20160320638-A1 Transparent Optical Article Having a Reduced Yellowness Appearance ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE (FR) 2016-11-03 US disclosed
US-20160320636-A1 Transparent Optical Article Having a Colorless Apperance ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) 2016-11-03 US disclosed
EP-3087419-A1 TRANSPARENT OPTICAL ARTICLE HAVING A REDUCED YELLOWNESS APPEARANCE Essilor International (Compagnie Générale D'Optique) (FR) 2016-11-02 EP disclosed
EP-2887129-A1 Transparent optical article having a colorless appearance ESSILOR INTERNATIONAL (Compagnie Générale d'Optique) (FR) 2015-06-24 EP disclosed
EP-0741333-B2 Photopolymerizable compositions AGFA CORP (US) 2007-06-27 EP disclosed
EP-0741333-B1 Photopolymerizable compositions AGFA CORP (US) 2000-07-12 EP disclosed
US-5707781-A Photopolymerizable compositions having acyl or diacyl phosphine oxide and a fluorescent optical brightner BAYER CORPORATION (US) 1998-01-13 US disclosed
EP-0741333-A1 Photopolymerizable compositions Bayer Corporation (US) 1996-11-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10308618-B2 Blue light cutting optical material comprising a benzotriazole UV absorber TPMT, PPOX, CYBA NPC1 3941/4885TP53 4027/4885SMN1; SMN2 4368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.